United States · FDA National Drug Code directory
Jardiance
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0597-0152_09daa78d-f417-436c-a29e-029c015ca6d6
- Product NDC
- 0597-0152
- Form
- TABLET, FILM COATED
- Composition / generic term
- Empagliflozin
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140801
- Source listing expiry
- 20271231
Source-listed ingredients
- EMPAGLIFLOZIN — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (0597-0152-07) / 7 TABLET, FILM COATED in 1 BOTTLE · 0597-0152-07
- 30 TABLET, FILM COATED in 1 BOTTLE (0597-0152-30) · 0597-0152-30
- 30 BLISTER PACK in 1 CARTON (0597-0152-37) / 1 TABLET, FILM COATED in 1 BLISTER PACK · 0597-0152-37
- 90 TABLET, FILM COATED in 1 BOTTLE (0597-0152-90) · 0597-0152-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →